Chronic hepatitis E virus infection and treatment

Journal of Clinical and Experimental Hepatology

Volumn 3, Issue 2, 2013, Pages 134-140

  Kamar, Nassim ^a,b,c   Izopet, Jacques ^b,c   Dalton, Harry R ^d  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

Chronic infection; Cirrhosis; Extra hepatic symptoms; Hepatitis E virus; Ribavirin

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ANEMIA; ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; DRUG DOSE REDUCTION; GENOTYPE; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HEPATITIS E; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY DISEASE; LIVER CIRRHOSIS; NEUROLOGIC DISEASE; NONHUMAN; ORGAN TRANSPLANTATION; PANCREATITIS; PRIORITY JOURNAL; RETRANSPLANTATION; REVIEW; SEROCONVERSION; SEROPREVALENCE; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRAL CLEARANCE; VIRUS TRANSMISSION;

EID: 84879783850     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2013.05.003     Document Type: Review

References (110)

1. Kamar N., Bendall R., Legrand-Abravanel F., et al. Hepat E Lancet 2012, 379:2477-2488.
2. Kamar N., Selves J., Mansuy J.M., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. NEngl J Med 2008, 358:811-817.
3. Ollier L., Tieulie N., Sanderson F., et al. Chronic hepatitis after hepatitis e virus infection in a patient with non-Hodgkin lymphoma taking Rituximab. Ann Intern Med 2009, 150:430-431.
4. Dalton H.R., Bendall R., Keane F., Tedder R., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. NEngl J Med 2009, 361:1025-1027.
5. Kamar N., Rostaing L., Legrand-Abravanel F., Izopet J. How should hepatitis E virus be defined in organ transplant recipients?. Am J Transplant 2013, 10.1111/ajt.12253.
6. Drobeniuc J., Meng J., Reuter G., et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010, 51:e24-e27.
7. Bendall R., Ellis V., Ijaz S., Ali R., Dalton H. Acomparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. JMed Virol 2010, 82:799-805.
8. Baylis S.A., Hanschmann K.M., Blumel J., Nubling C.M. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. JClin Micribiol 2011, 49:1234-1239.
9. Legrand-Abravanel F., Kamar N., Sandres-Saune K., et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011, 17:30-37.
10. Legrand-Abravanel F, Lhomme S, Chapuy-Regaud S, etal. Hepatitis E virus reinfections in solid-organ-transplant patients recipients having anti-HEV antibodies. [Submited].
11. Pischke S., Suneetha P.V., Baechlein C., et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010, 16:74-82.
12. Pischke S., Stiefel P., Franz B., et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012, 12:3128-3133.
13. Haagsma E.B., Niesters H.G., van den Berg A.P., et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009, 15:1225-1228.
14. Pas S.D., de Man R.A., Mulders C., et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012, 18:869-872.
15. Buti M., Cabrera C., Jardi R., Castells L., Esteban R. Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection?. Liver Transpl 2010, 16:106-107.
16. Moal V., Legris T., Burtey S., et al. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. JMed Virol 2012, 85:462-471.
17. Riezebos-Brilman A., Puchhammer-Stöckl E., Van der Weide H., et al. Chronic hepatitis E infection in lung transplant recipients. JHeart Lung Transplant 2013, 32:341-346.
18. Halac U., Béland K., Lapierre P., et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012, 64:597-603.
19. Motte A., Roquelaure B., Galambrun C., Bernard F., Zandotti C., Colson P. Hepatitis E in three immunocompromized children in southeast France. JClin Virol 2012, 53:162-166.
20. Hoerning A., Hegen B., Wingen A.M., et al. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients-a single-center experience. Pediatr Transplant 2012, 16:742-747.
21. Junge N., Pischke S., Baumann U., et al. Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatr Transplant 2013 Apr 3, [Epub ahead of print]. 10.1111/petr.12077.
22. Knoenecke C., Pischke S., Heim A., et al. Chronic hepatitis E in hematopoietic stem cell transplant patients in low-endemic country. Transplant Infect Dis 2012, 14:103-106.
23. Abravanel F., Mansuy J.M., Huynh A., et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. JClin Virol 2012, 54:152-155.
24. Tavitian S., Peron J.M., Huynh A., et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. JClin Virol 2010, 49:141-144.
25. Halac U., Beland K., Lapierre P., et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. JPediatr 2012, 160(5):871-874.
26. le Coutre P., Meisel H., Hofmann J., et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009, 58:699-702.
27. Legrand-Abravanel F., Kamar N., Sandres-Saune K., et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. JInfect Dis 2010, 202:835-844.
28. Emerson S.U., Arankalle V.A., Purcell R.H. Thermal stability of hepatitis E virus. JInfect Dis 2005, 192:930-933.
29. Mansuy J.M., Bendall R., Legrand-Abravanel F., et al. Hepatitis E virus antibody in blood donors, France. Emerg Infect Dis 2011, 17:2309-2312.
30. Tamura A., Shimizu Y.K., Tanaka T., et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007, 37:113-120.
31. Khuroo M.S., Kamili S., Yattoo G.N. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. JGastroenterol Hepatol 2004, 19:778-784.
32. Mitsui T., Tsukamoto Y., Yamazaki C., et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. JMed Virol 2004, 74:563-572.
33. Schlosser B., Stein A., Neuhaus R., et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. JHepatol 2012, 56:500-502.
34. Ayoola E.A., Want M.A., Gadour M.O., Al-Hazmi M.H., Hamza M.K. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia. JMed Virol 2002, 66:329-334.
35. Mansuy J.M., Huynh A., Abravanel F., Recher C., Peron J.M., Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis 2009, 48:373-374.
36. Gerolami R., Moal V., Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. NEngl J Med 2008, 358:859-860.
37. Kamar N., Mansuy J.M., Cointault O., et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008, 8:1744-1748.
38. Haagsma E.B., van den Berg A.P., Porte R.J., et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008, 14:547-553.
39. Gerolami R., Moal V., Picard C., Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. JHepatol 2009, 50:622-624.
40. Kamar N., Abravanel F., Selves J., et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010, 89:353-360.
41. Mallet V., Nicand E., Sultanik P., et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010, 153:85-89.
42. Vantyghem M.C., Mathurin P., Hober D., et al. Partial graft recovery following eradication of hepatitis E virus infection after successful isletallograft transplantation. Transpl Int 2010, 24:e13-e15.
43. Chaillon A., Sirinelli A., De Muret A., Nicand E., d'Alteroche L., Goudeau A. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. JHeart Lung Transplant 2011, 30:841-843.
44. Halleux D., Kanaan N., Kabamba B., Thomas I., Hassoun Z. Hepatitis E virus: an underdiagnosed cause of chronic hepatitis in renal transplant recipients. Transpl Infect Dis 2012, 14:99-102.
45. de Niet A., Zaaijer H.L., Ten Berge I., Weegink C.J., Reesink H.W., Beuers U. Chronic hepatitis E after solid organ transplantation. Neth J Med 2012, 70:261-266.
46. Koning L., Pas S.D., de Man R.A., et al. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. JHeart Lung Transplant 2013, 32:78-85.
47. Te H.S., Drobeniuc J., Kamili S., Dong C., Hart J., Sharapov U.M. Hepatitis e virus infection in a liver transplant recipient in the United States: a case report. Transplant Proc 2013, 45:810-813.
48. Maddukuri V.C., Russo M.W., Ahrens W.A., et al. Chronic hepatitis e with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient. Dig Dis Sci 2013, [Epub ahead of print].
49. Kamar N., Garrouste C., Haagsma E.B., et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140:1481-1489.
50. Dalton H.R., Bendall R., Ijaz S., Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8:698-709.
51. Lhomme S., Abravanel F., Dubois M., et al. HEV quasispecies and the outcome of acute hepatitis e in solid-organ transplant patients. JVirol 2012, 86:10006-10014.
52. Suneetha P.V., Pischke S., Schlaphoff V., et al. HEV-specific T-cell responses are associated with control of HEV infection. Hepatology. 2012, 55:695-708.
53. Kamar N., Legrand-Abravanel F., Dalton H.R., Izopet J. Hepatitis E virus-specific T-cell response after transplantation. Hepatology. 2012, 55:1643. author reply 4.
54. Kamar N., Rostaing L., Abravanel F., et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010, 50:e30-e33.
55. Haagsma E.B., Riezebos-Brilman A., van den Berg A.P., Porte R.J., Niesters H.G. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010, 16:474-477.
56. Dong C., Zafrullah M., Mixson-Hayden T., et al. Suppression of interferon-alpha signaling by hepatitis E virus. Hepatology 2012, 55:1324-1332.
57. Kamar N., Rostaing L., Abravanel F., et al. Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection. Gastroenterology 2010, 139:1612-1618.
58. Pischke S., Hardkte S., Bode U., et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 2013, 33:722-726.
59. Peron J.M., Dalton H., Izopet J., Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?. JHepatol 2011, 54:1323-1324. author reply 4-5.
60. Kamar N., Izopet J., Rostaing L. No reactivation of hepatitis E virus after kidney retransplantation. Am J Transplant 2012, 12:507-508.
61. Shukla P., Nguyen H.T., Torian U., et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A 2011, 108:2438-2443.
62. Kenfak-Foguena A., Schoni-Affolter F., Burgisser P., et al. Hepatitis E virus seroprevalence and chronic infections in patients with HIV. Switzerland Emerg Infect Dis 2011, 17:1074-1078.
63. Renou C., Lafeuillade A., Cadranel J.F., et al. Hepatitis E virus in HIV-infected patients. AIDS 2010, 24:1493-1499.
64. Kaba M., Richet H., Ravaux I., et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. JMed Virol 2011, 83:1704-1716.
65. Crum-Cianflone N.F., Curry J., Drobeniuc J., et al. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis 2012, 18:502-506.
66. Jardi R., Crespo M., Homs M., et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med 2012, 13:379-383.
67. Colson P., Dhiver C., Gerolami R. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clin Microbiol Infect 2008, 14:1176-1180.
68. Thoden J., Venhoff N., Miehle N., et al. Hepatitis E and jaundice in an HIV-positive pregnant woman. AIDS 2008, 22:909-910.
69. Curry J.A., Adams N., Crum-Cianflone N.F. Acute hepatitis E virus infection in an HIV-infected person in the United States. Ann Intern Med 2009, 150:226-227.
70. Colson P., Kaba M., Moreau J., Brouqui P. Hepatitis E in an HIV-infected patient. JClin Virol 2009, 45:269-271.
71. Colson P., Gerolami R., Moreau J., Borentain P., Brouqui P. Concurrent autochthonous acute hepatitis E and hepatitis B reverse seroconversion in an HIV-1-infected patient: one virus may hide another. Int J Infect Dis 2009, 14:e357.
72. Colson P., Dhiver C., Poizot-Martin I., Tamalet C., Gerolami R. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. JViral Hepat 2011, 18:227-228.
73. Sellier P., Mazeron M.C., Tesse S., et al. Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels. Virol J 2011, 8:171.
74. van Welzen B.J., Verduyn Lunel F.M., Meindertsma F., Hoepelman A.I., Arends J.E. Hepatitis E virus as a causative agent of unexplained liver enzyme elevations in HIV-infected patients. JAcquir Immune Defic Syndr 2012, 60:e65-e67.
75. Pischke S., Ho H., Urbanek F., et al. Hepatitis E in HIV-positive patients in a low-endemic country. JViral Hepat 2010, 17:598-599.
76. Keane F., Gompels M., Bendall R., et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med 2012, 13(1):83-88.
77. Madejon A., Vispo E., Bottecchia M., Sanchez-Carrillo M., Garcia-Samaniego J., Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. JViral Hepat 2009, 16:895-896.
78. Kaba M., Brouqui P., Richet H., et al. Hepatitis E virus infection in sheltered homeless persons, France. Emerg Infect Dis 2010, 16:1761-1763.
79. Larrat S., Gaillard S., Baccard M., et al. Hepatitis E virus infection in sheltered homeless persons, France. Emerg Infect Dis 2012, 18:1031. author reply 2.
80. Dalton H., Keane F., Bendall R., Mathew J., Ijaz S. Treatment of chronic hepatitis E in a HIV positive patient. Ann Intern Med 2011, 155:479-480.
81. Jagjit Singh G.K., Ijaz S., Rockwood N., et al. Chronic hepatitis E virus as a cause of cryptogenic cirrhosis in HIV. JInfect 2013, 66(1):103-106.
82. Andersson M.I., Preiser W., Maponga T.G., et al. Immune reconstitution hepatitis E: a neglected complication of antiretroviral therapy in Africa?. AIDS 2013, 27:487-489.
83. Peron J.M., Mansuy J.M., Recher C., et al. Prolonged hepatitis E in an immunocompromised patient. JGastroenterol Hepatol 2006, 21:1223-1224.
84. Alric L., Bonnet D., Laurent G., Kamar N., Izopet J. Chronic hepatitis E virus infection: successful virologic response to pegylated Interferon-{alpha} therapy. Ann Intern Med 2010, 153:135-136.
85. Alric L., Bonnet D., Beynes-Rauzy O., Izopet J., Kamar N. Definitive clearance of a chronic hepatitis e virus infection with ribavirin treatment. Am J Gastroenterol 2011, 106:1562-1563.
86. Sood A., Midha V., Sood N. Guillain-Barre syndrome with acute hepatitis E. Am J Gastroenterol 2000, 95:3667-3668.
87. Kamani P., Baijal R., Amarapurkar D., et al. Guillain-Barre syndrome associated with acute hepatitis E. Indian J Gastroenterol 2005, 24:216.
88. Loly J.P., Rikir E., Seivert M., et al. Guillain-Barre syndrome following hepatitis E. World J Gastroenterol 2009, 15:1645-1647.
89. Chalupa P., Holub M. Jaundice complicated by an atypical form of Guillain-Barre syndrome. JClin Virol 2010, 49:229-230.
90. Despierres L.A., Kaphan E., Attarian S., et al. Neurologic disorders and hepatitis E, France. Emerg Infect Dis 2010, 2011(17):1510-1512.
91. Maurissen I., Jeurissen A., Strauven T., Sprengers D., De Schepper B. First case of anti-ganglioside GM1-positive Guillain-Barre syndrome due to hepatitis E virus infection. Infection 2012, 40(3):323-326.
92. Cronin S., McNicholas R., Kavanagh E., Reid V., O'Rourke K. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection. Ir J Med Sci 2011, 180:255-257.
93. Tse A.C., Cheung R.T., Ho S.L., Chan K.H. Guillain-Barre syndrome associated with acute hepatitis E infection. JClin Neurosci 2012, 19:607-608.
94. Dixit V.K., Abhilash V.B., Kate M.P., Jain A.K. Hepatitis E infection with Bell's palsy. JAssoc Physicians India 2006, 54:418.
95. Fong F., Illahi M. Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg 2009, 111:193-195.
96. Rianthavorn P., Thongmee C., Limpaphayom N., Komolmit P., Theamboonlers A., Poovorawan Y. The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand J Infect Dis 2010, 42:395-400.
97. Mandal K., Chopra N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr 2006, 43:365-366.
98. Kejariwal D., Roy S., Sarkar N. Seizure associated with acute hepatitis E. Neurology 2001, 57:1935.
99. Kamar N., Bendall R.P., Peron J.M., et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011, 17:173-179.
100. Kamar N., Izopet J., Cintas P., et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 2010, 10:1321-1324.
101. Del Bello A., Arne-Bes M.C., Lavayssiere L., Kamar N. Hepatitis E virus-induced severe myositis. JHepatol 2012, 57(5):1152-1153.
102. Kamar N., Mansuy J.M., Esposito L., et al. Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. Am J Kidney Dis 2005, 45:193-196.
103. Kamar N., Weclawiack H., Guilbeaud-Frugier C., et al. Hepatitis E virus and the kidney in solid-organ-transplant patients. Transplantation 2012, 93:617-623.
104. Sinha S., Jha R., Lakhtakia S., Narayan G. Acute pancreatitis following kidney transplantation - role of viral infections. Clin Transplant 2003, 17:32-36.
105. Bhagat S., Wadhawan M., Sud R., Arora A. Hepatitis viruses causing pancreatitis and hepatitis: a case series and review of literature. Pancreas 2008, 36:424-427.
106. Thapa R., Biswas B., Mallick D., Ghosh A. Acute pancreatitis-complicating hepatitis E virus infection in a 7-year-old boy with glucose 6 phosphate dehydrogenase deficiency. Clin Pediatr 2009, 48:199-201.
107. Deniel C., Coton T., Brardjanian S., Guisset M., Nicand E., Simon F. Acute pancreatitis: a rare complication of acute hepatitis E. JClin Virol 2011, 51:202-204.
108. Colson P., Payraudeau E., Leonnet C., et al. Severe thrombocytopenia associated with acute hepatitis E virus infection. JClin Microbiol 2008, 46:2450-2452.
109. Fourquet E., Mansuy J.M., Bureau C., et al. Severe thrombocytopenia associated with acute autochthonous hepatitis E. JClin Virol 2010, 48:73-74.
110. Shah S.A., Lal A., Idrees M., et al. Hepatitis E virus-associated aplastic anaemia: the first case of its kind. JClin Virol 2012, 54:96-97.